Vanguard Group Inc. raised its position in Docusign Inc. (NASDAQ:DOCU – Free Report) by 1.1% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 21,625,551 shares of the company’s stock after purchasing an additional 225,525 shares during the period. Vanguard Group Inc. owned approximately 10.75% of Docusign worth $1,558,986,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Norges Bank acquired a new position in shares of Docusign in the 2nd quarter valued at $140,987,000. Third Point LLC bought a new position in Docusign during the second quarter worth about $48,681,000. Jupiter Asset Management Ltd. grew its stake in Docusign by 88.3% in the second quarter. Jupiter Asset Management Ltd. now owns 1,316,440 shares of the company’s stock valued at $102,538,000 after acquiring an additional 617,200 shares during the period. Alliancebernstein L.P. grew its stake in Docusign by 132.8% in the second quarter. Alliancebernstein L.P. now owns 868,531 shares of the company’s stock valued at $67,650,000 after acquiring an additional 495,380 shares during the period. Finally, Nippon Life Global Investors Americas Inc. increased its holdings in shares of Docusign by 134.1% in the third quarter. Nippon Life Global Investors Americas Inc. now owns 508,590 shares of the company’s stock worth $36,664,000 after acquiring an additional 291,380 shares in the last quarter. 77.64% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
DOCU has been the topic of several recent analyst reports. Wells Fargo & Company cut their price objective on Docusign from $85.00 to $75.00 and set an “equal weight” rating on the stock in a report on Friday, December 5th. Robert W. Baird dropped their target price on shares of Docusign from $90.00 to $75.00 and set a “neutral” rating on the stock in a report on Friday, December 5th. Zacks Research cut shares of Docusign from a “strong-buy” rating to a “hold” rating in a report on Monday, November 24th. BTIG Research lowered their price objective on shares of Docusign from $88.00 to $70.00 and set a “buy” rating for the company in a research report on Wednesday. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Docusign from $80.00 to $78.00 and set a “neutral” rating on the stock in a report on Friday, December 5th. Six investment analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $82.80.
Insider Transactions at Docusign
In other Docusign news, insider Robert Chatwani sold 13,818 shares of the firm’s stock in a transaction that occurred on Wednesday, December 17th. The stock was sold at an average price of $68.33, for a total value of $944,183.94. Following the completion of the transaction, the insider directly owned 70,197 shares in the company, valued at $4,796,561.01. This trade represents a 16.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CRO Paula Hansen sold 6,000 shares of the business’s stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $67.05, for a total value of $402,300.00. Following the transaction, the executive directly owned 68,970 shares in the company, valued at $4,624,438.50. This trade represents a 8.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 78,292 shares of company stock worth $5,374,260. 1.01% of the stock is owned by insiders.
Key Stories Impacting Docusign
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: Bonterms launched a DocuSign IAM extension app, which could increase platform stickiness and partner-driven adoption for DocuSign’s e-signature workflows. Bonterms Launches DocuSign IAM Extension App
- Positive Sentiment: Zacks published bullish/value-oriented analysis arguing DocuSign is a long-term value pick, which can support investor interest from value-focused funds. Why DocuSign is a Top Value Stock for the Long-Term
- Neutral Sentiment: Comparative pieces (DOCU vs ADYEY) and a Benzinga analyst-rating roundup provide context but are unlikely to move shares dramatically by themselves. DOCU vs. ADYEY: Which Stock Is the Better Value Option?
- Neutral Sentiment: A Benzinga deep-dive summarizes 12 analyst ratings — useful for context but not a single, market-moving consensus. Deep Dive Into DocuSign Stock: Analyst Perspectives
- Neutral Sentiment: Reported short-interest data shows odd/zero values and a 0.0 days-to-cover figure, which appears to be a data reporting anomaly rather than a clear signal of rising bearish positioning.
- Negative Sentiment: HSBC’s Stephen Bersey reiterated a Hold and cut his price target from $77 to $53, citing weaker growth prospects — a clear negative for sentiment and expectations. What Makes Docusign (DOCU) Attractive
- Negative Sentiment: BTIG trimmed its price target (reported ahead of earnings commentary), another sign analysts are moderating expectations for near-term performance. BTIG Lowers DocuSign Price Target to $70
- Negative Sentiment: Recent market-coverage notes and headlines highlight that DOCU has underperformed the broader market in recent sessions, reinforcing downside momentum. DocuSign Suffers a Larger Drop Than the General Market
- Negative Sentiment: Technically, DOCU is trading well below its 50- and 200-day moving averages, which may keep momentum traders and some funds sidelined until near-term trends improve.
Docusign Stock Up 0.8%
Shares of DOCU opened at $44.48 on Friday. Docusign Inc. has a twelve month low of $41.53 and a twelve month high of $94.67. The stock has a market capitalization of $8.91 billion, a P/E ratio of 31.10, a P/E/G ratio of 1.93 and a beta of 1.00. The company has a 50 day moving average of $58.57 and a 200-day moving average of $67.59.
Docusign Profile
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
See Also
- Five stocks we like better than Docusign
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
